Purchase this article with an account.
H. Monique H. Hurks, Jessica A. W. Metzelaar-Blok, Ed R. Barthen, Aeilko H. Zwinderman, Didi De Wolff-Rouendaal, Jan E. E. Keunen, Martine J. Jager; Expression of Epidermal Growth Factor Receptor: Risk Factor in Uveal Melanoma. Invest. Ophthalmol. Vis. Sci. 2000;41(8):2023-2027.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
purpose. To investigate the prognostic significance of the expression of
epidermal growth factor receptor (EGFR) in uveal melanoma. EGFR is a
transmembrane glycoprotein, and its expression has been correlated with
the development of metastases in various malignancies.
methods. Frozen sections from 22 primary uveal melanomas were examined for EGFR
expression by a three-step immunoperoxidase staining, using a mouse
anti-human EGFR IgG2b monoclonal antibody. The results were compared
with patient survival and clinical and histopathologic parameters.
results. EGFR expression could not be determined on one tumor due to excessive
pigmentation. Two patients died of causes unrelated to melanoma, and
two patients were lost to follow-up. Out of 21 tumors, six tumors
showed immunoreactivity for EGFR. Five of these six patients (83%)
died due to metastases, compared with 2 (17%) of 12 patients with no
EGFR expression (Kaplan–Meier analysis P = 0.0004).
EGFR-positive tumors tended to have a greater tumor prominence and a
higher mitotic rate.
conclusions. The expression of EGFR was significantly correlated with death due to
metastatic disease and therefore can be regarded as an important
prognostic factor in human uveal melanoma.
This PDF is available to Subscribers Only